5625-67-2 | Piperazin-2-one

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$7.00	$5.00
10g	98%	in stock	$10.00	$7.00
25g	98%	in stock	$21.00	$15.00
100g	98%	in stock	$73.00	$52.00
500g	98%	in stock	$248.00	$174.00

Description

• Catalog Number: AB62958
• Chemical Name: Piperazin-2-one
• CAS Number: 5625-67-2
• Molecular Formula: C4H8N2O
• Molecular Weight: 100.1191
• MDL Number: MFCD01318687
• SMILES: O=C1CNCCN1
• NSC Number: 27441

Computed Properties

• Complexity: 81.8
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• XLogP3: -1.1

Literature

• Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.

  Bioorganic & medicinal chemistry letters 20120115

• Identification of novel sildenafil-analogues in an adulterated herbal food supplement.

  Journal of pharmaceutical and biomedical analysis 20111205

• Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.

  Journal of medicinal chemistry 20111027

• Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.

  Bioorganic & medicinal chemistry letters 20110615

• 3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.

  Bioorganic & medicinal chemistry letters 20110601

• A submarine journey: the pyrrole-imidazole alkaloids.

  Marine drugs 20091201

• Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity.

  BMC bioinformatics 20090101

• Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines.

  Journal of asthma and allergy 20090101

• Computer applications for prediction of protein-protein interactions and rational drug design.

  Advances and applications in bioinformatics and chemistry : AABC 20090101

• Discovery of orally bioavailable 1,3,4-trisubstituted 2-oxopiperazine-based melanocortin-4 receptor agonists as potential antiobesity agents.

  Journal of medicinal chemistry 20081009

• Concise synthesis of the CDE ring system of tetrahydroisoquinoline alkaloids using carbophilic Lewis acid-catalyzed hydroamidation and oxidative Friedel-Crafts cyclization.

  The Journal of organic chemistry 20080704

• Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors.

  Bioorganic & medicinal chemistry letters 20080601

• Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers.

  Bioorganic & medicinal chemistry 20080201

• [Piperazines as model substrate for oxidations].

  Die Pharmazie 20061001

• New class of nucleophiles for palladium-catalyzed asymmetric allylic alkylation. Total synthesis of agelastatin A.

  Journal of the American Chemical Society 20060510

• Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-I.

  Organic & biomolecular chemistry 20060507

• (13)C NMR spectral assignment of 1,4-diarylpiperazinones.

  Magnetic resonance in chemistry : MRC 20060101

• Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors III. Effect of ring opening of piperazinone moiety on inhibition.

  Chemical & pharmaceutical bulletin 20040401

• Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I.

  Bioorganic & medicinal chemistry letters 20040209

• Synthesis of a library of 3-oxopiperazinium and perhydro-3-oxo-1,4-diazepinium derivatives and identification of bioactive compounds.

  Journal of combinatorial chemistry 20040101

• alpha-Keto amides as precursors to heterocycles--generation and cycloaddition reactions of piperazin-5-one nitrones.

  Organic & biomolecular chemistry 20030407

• Synthesis of 1,4-diazines by ring expansion of 1,3-diazines.

  The Journal of organic chemistry 20030321

• Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket.

  Journal of medicinal chemistry 20030227

• Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: synthesis and pharmacological evaluation of 2-oxopiperazine derivatives.

  Journal of medicinal chemistry 20010719

• The design of competitive, small-molecule inhibitors of coagulation factor Xa.

  Current topics in medicinal chemistry 20010601

• 3,8-Diazabicyclo[3.2.1]octan-2-one peptide mimetics: synthesis of a conformationally restricted inhibitor of farnesyltransferase.

  Organic letters 20010322

• Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferase.

  Bioorganic & medicinal chemistry letters 20010226

• Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitors.

  Bioorganic & medicinal chemistry letters 20010212